Management of selected lipid abnormalities - Hypertriglyceridemia, low HDLcholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation

Authors
Rader, DJ Rosas, S
Citation
Dj. Rader et S. Rosas, Management of selected lipid abnormalities - Hypertriglyceridemia, low HDLcholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation, MED CLIN NA, 84(1), 2000, pp. 43
Citations number
126
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
MEDICAL CLINICS OF NORTH AMERICA
ISSN journal
00257125 → ACNP
Volume
84
Issue
1
Year of publication
2000
Database
ISI
SICI code
0025-7125(200001)84:1<43:MOSLA->2.0.ZU;2-A
Abstract
Many patients with premature coronary artery disease do not have elevated L DL cholesterol levels, instead, they have elevated triglycerides or low hig h-density lipoprotein (HDL) cholesterol levels (or both). Data suggest that intervention to modulate these lipoprotein fractions may reduce cardiovasc ular risk.